UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Magnolia Oil & Gas
MGY
$6.16B
| $2.72M | ﹤0.01% |
124,459
-11,010
| -8% | -$244K |
|
1452
Privia Health
PRVA
$2.86B
| $2.72M | ﹤0.01% |
98,379
+13,057
| +15% | +$345K |
|
1453
Ameris Bancorp
ABCB
$5.88B
| $2.71M | ﹤0.01% |
74,090
+6,313
| +9% | +$284K |
|
1454
Cal-Maine
CALM
$3.85B
| $2.71M | ﹤0.01% |
44,443
+1,755
| +4% | +$97.9K |
|
1455
Werner Enterprises
WERN
$2.2B
| $2.7M | ﹤0.01% |
59,434
+2,578
| +5% | +$117K |
|
1456
Kadant
KAI
$3.94B
| $2.69M | ﹤0.01% |
+12,889
| New | +$2.62M |
|
1457
World Kinect Corp
WKC
$1.89B
| $2.68M | ﹤0.01% |
104,814
-7,502
| -7% | -$204K |
|
|
ARNC
1458
DELISTED
Arconic Corporation
ARNC
| $2.67M | ﹤0.01% |
101,923
-7,595
| -7% | -$187K |
|
1459
Under Armour
UAA
$2.5B
| $2.67M | ﹤0.01% |
281,701
-25,769
| -8% | -$268K |
|
|
VRNT
1460
DELISTED
Verint Systems
VRNT
| $2.67M | ﹤0.01% |
71,659
+2,119
| +3% | +$79K |
|
1461
Sotera Health
SHC
$5.41B
| $2.66M | ﹤0.01% |
148,515
+11,507
| +8% | +$192K |
|
|
UHT
1462
Universal Health Realty Income Trust
UHT
$576M
| $2.66M | ﹤0.01% |
+55,276
| New | +$2.85M |
|
1463
Energizer
ENR
$1.5B
| $2.66M | ﹤0.01% |
76,599
+16,283
| +27% | +$577K |
|
1464
CNX Resources
CNX
$5.32B
| $2.65M | ﹤0.01% |
165,663
-4,083
| -2% | -$64.9K |
|
1465
Allogene Therapeutics
ALLO
$725M
| $2.63M | ﹤0.01% |
+533,236
| New | +$3.42M |
|
1466
Albany International
AIN
$1.73B
| $2.63M | ﹤0.01% |
+29,470
| New | +$2.97M |
|
1467
Cracker Barrel
CBRL
$1.25B
| $2.63M | ﹤0.01% |
23,133
+1,292
| +6% | +$141K |
|
1468
Xerox
XRX
$427M
| $2.62M | ﹤0.01% |
170,068
+10,510
| +7% | +$170K |
|
1469
Harmonic Inc
HLIT
$1.26B
| $2.61M | ﹤0.01% |
179,169
+9,867
| +6% | +$136K |
|
1470
Shake Shack
SHAK
$2.89B
| $2.61M | ﹤0.01% |
47,022
+3,545
| +8% | +$196K |
|
1471
WSFS Financial
WSFS
$4.12B
| $2.59M | ﹤0.01% |
68,912
+2,085
| +3% | +$95.7K |
|
|
VRTV
1472
DELISTED
VERITIV CORPORATION
VRTV
| $2.59M | ﹤0.01% |
19,161
+432
| +2% | +$55.3K |
|
1473
Greif
GEF
$4.97B
| $2.58M | ﹤0.01% |
40,689
+5,469
| +16% | +$367K |
|
1474
First Merchants
FRME
$2.66B
| $2.56M | ﹤0.01% |
77,830
+4,075
| +6% | +$161K |
|
1475
Glaukos
GKOS
$10.7B
| $2.56M | ﹤0.01% |
51,044
-375
| -0.7% | -$18.2K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.